Your Space - Health and Fitness

Due to the fact that multiple sclerosis is a complex disease that primarily causes impairments at the level of the central nervous system (CNS) that later spread in mult

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

iple regions of the body, the produced symptoms are various and can perceived at different intensities. In its first stages of progression, multiple sclerosis generates

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

a wide variety of mild to moderate neurological symptoms. In more advanced phases of the disease, when other body systems also become affected, multiple sclerosis may ca

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

se many different physical manifestations.

The undesired effects of multiple sclerosis on the human body are often irreversible, rendering prompt medical intervention c

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

rucial for reducing the development of complications. Despite the fact that there is no specific cure for multiple sclerosis in present, the existing forms of treatment

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

can successfully control the progression rate and the symptoms characteristic to this type of disease. Thus, patients are usually administered an appropriate treatment a

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

soon as they are diagnosed with multiple sclerosis.

The symptoms of multiple sclerosis are diversified and they can occur in many different body regions. Most patients

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

have individualized symptoms of multiple sclerosis, manifestations that generally occur in episodes, or flares. The intensity, frequency and duration of multiple sclero

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

sis symptoms are strongly influenced by the stage of progression and the specific subtype of the disease. The progression of multiple sclerosis is often unpredictable, a

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

ternating between phases of symptomatic remission and phases of relapse. The majority of patients diagnosed with multiple sclerosis experience recidivating symptoms that

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

generally tend to amplify in the stages of relapse.

Common symptoms of multiple sclerosis comprise generalized fatigue, body weakness, sensations of tingling, burning,

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

pain and numbness in the muscles, loss of dexterity and poorly coordinated body movement. Other common symptoms produced by multiple sclerosis are: vision problems, sha

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

ing of the limbs, spasms, convulsions, inability to maintain balance, dizziness, vertigo and confusion. In more advanced phases of disease, multiple sclerosis can also g

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

enerate manifestations such as partial paralysis, renal and gastrointestinal problems.

Neuropsychological symptoms of multiple sclerosis generally occur in the incipien

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

t stages of disease, gradually amplifying over time. Such symptoms include inaccurate perceptions, decreased concentration, short-term memory loss (amnesia), reduced jud

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ment and unexpected changes in behavior. A symptom that is commonly seen in patients with multiple sclerosis is depression. Persons with multiple sclerosis eventually be

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

come depressed and refuse any form of social interaction. Although depression and other similar neuropsychological symptoms are a common problem among patients with mult

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

iple sclerosis, medical scientists haven’t yet unveiled the exact origin of such manifestations.

While some groups of medical scientists believe that most neuropsycholo

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ical symptoms are solely the result of impairments at the level of the central nervous system, others believe that they are a consequence of prolonged treatment. This se

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

cond opinion is considered to be more accurate, as the psychological symptoms of patients with multiple sclerosis gradually ameliorate after the treatment is interrupted

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.yourspace.org.ua/article/242444/yourspace-The-Wide-Spectrum-of-Multiple-Sclerosis-Symptoms.html">The Wide Spectrum of Multiple Sclerosis Symptoms</a>

BB link (for phorums):
[url=http://www.yourspace.org.ua/article/242444/yourspace-The-Wide-Spectrum-of-Multiple-Sclerosis-Symptoms.html]The Wide Spectrum of Multiple Sclerosis Symptoms[/url]

A home business is the most economical way to be your own boss. You don’t have to rent office space, there’s no commute, and your expenses are tax deductible. Still, you will have to get the word out about your business if you want customers. Here are some ways to save money.

You can help others grasp the essence of something intangible - something that can't be seen or touched - by using a tangible item to convey a message about it.

Development of the educational framework with individualized mental health assessment pattern may formerly cover the evaluation of perception of whole.

Tags

Links

Your Space - The Wide Spectrum of Multiple Sclerosis Symptoms

Related Articles: